General Information of Drug (ID: DMDXMH9)

Drug Name
PMID27109571-Compound-3 Drug Info
Cross-matching ID
PubChem CID
56592603
TTD Drug ID
DMDXMH9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-5 DMOZKAH N. A. N. A. Patented [1]
PMID27109571-Compound-41 DMY4IAV N. A. N. A. Patented [1]
PMID27109571-Compound-4 DMYRG0Q N. A. N. A. Patented [1]
PMID27109571-Compound-32 DM4IS6Q N. A. N. A. Patented [1]
PMID27109571-Compound-42 DMZOI3K N. A. N. A. Patented [1]
PMID27109571-Compound-35 DMGV4PT N. A. N. A. Patented [1]
PMID27109571-Compound-39 DMBHJDR N. A. N. A. Patented [1]
PMID27109571-Compound-37 DMJCAOD N. A. N. A. Patented [1]
PMID27109571-Compound-40 DMQ83EV N. A. N. A. Patented [1]
PMID27109571-Compound-34 DM5OXUK N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein (FABP) TTMY6L1 NOUNIPROTAC Inhibitor [1]

References

1 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.